Risk factors for fungal infection in paediatric liver transplant recipients
- 9 March 2005
- journal article
- Published by Wiley in Pediatric Transplantation
- Vol. 9 (2) , 220-225
Abstract
Abstract: Fungal infection (FI) is a major and potentially fatal complication in liver transplantation (LT). Published experience of FI in paediatric LT is limited. We therefore reviewed case records of 79 children, aged between 0.16 and 16 yr, who underwent LT between 1997 and 1998 to document the incidence of, and identify risk factors for, FI. Sixty‐eight pre‐, peri‐ and post‐LT variables were assessed in relation to FI by univariate and multivariate analyses. The major indications for LT were biliary atresia in 26 (33%) patients, fulminant hepatic failure in 16 (20%) and intrahepatic cholestasis in 11 (14%); eight patients required re‐LT. Thirty‐two (40.5%) children developed a FI within 1 yr of LT. The median time to FI was 42 days (range 1–342 days). Candida spp. caused 29 (90.7%) FIs; 21 (66%) of these were Candida albicans. Although FI was associated with increased mortality, most patients responded well to antifungal treatment. The variables independently associated with FI were pre‐LT fungal colonization and pyrexia and, post‐LT, bacterial infection, Epstein–Barr virus (EBV) infection and tacrolimus administration. Identifying risk factors for FI should contribute to the development of strategies for prophylaxis or preemptive therapy.Keywords
This publication has 33 references indexed in Scilit:
- Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind studyTransplantation, 2003
- Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients1Transplantation, 2002
- Candida infection in pediatric liver transplant recipientsLiver Transplantation and Surgery, 1999
- Invasive Fungal Infections in Liver Transplant Recipients Receiving Tacrolimus as the Primary Immunosuppressive AgentClinical Infectious Diseases, 1997
- RISK FACTORS OF INVASIVE CANDIDA AND NON-CANDIDA FUNGAL INFECTIONS AFTER LIVER TRANSPLANTATION1Transplantation, 1996
- Randomized Trial of Fluconazole versus Nystatin for the Prophylaxis of Candida Infection following Liver TransplantationThe Journal of Infectious Diseases, 1996
- MAJOR INFECTIOUS COMPLICATIONS AFTER ORTHOTOPIC LIVER TRANSPLANTATION AND COMPARISON OF OUTCOMES IN PATIENTS RECEIVING CYCLOSPORINE OR FK506 AS PRIMARY IMMUNOSUPPRESSIONTransplantation, 1995
- Bacterial and fungal colonization and infections using oral selective bowel decontamination in orthotopic liver transplantationsTransplant International, 1994
- Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysisJournal of Hepatology, 1993
- ACUTE RENAL TOXICITY WITH COMBINED USE OF AMPHOTERICIN B AND CYCLOSPORINE AFTER MARROW TRANSPLANTATIONTransplantation, 1983